NEHA KRISHNAMOHAN

Chief Financial Officer and EVP, Corporate Development Kinnate Biopharma Inc.

Neha Krishnamohan is Chief Financial Officer and Executive Vice President for Corporate Development at Kinnate Biopharma, Inc. She leads the public company’s strategic corporate finance operations, IR and PR, and guides business development and corporate strategy focused on expanding access to new targeted oncology therapeutics.

During a 13-year tenure at Goldman Sachs, Krishnamohan established herself as a senior leader in the healthcare coverage group and successfully executed over $100 billion in transactions in the biopharmaceutical, medical technology and tools/diagnostics sectors.

She has expanded equity research analyst coverage to seven covering analysts and grew the finance team by 40%, establishing an Investor Relations and Communications department to support the company’s growth.

Born in Singapore, Krishnamohan moved to the United State to pursue a degree; an early interest in science and healthcare led her to a dual degree in biomedical engineering and economics at Duke University.